PTJ
OPTN

Paul Tudor Jones’s OptiNose OPTN Stock Holding History

Paul Tudor Jones’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,124
Closed -$76K – 2491
2021
Q4 		$76K Sell
3,124
-27
-0.9% -$904 ﹤0.01% 2245
2021
Q3 		$142K Buy
3,151
+7
+0.2% +$294 ﹤0.01% 2343
2021
Q2 		$147K Buy
3,144
+246
+8% +$12.6K ﹤0.01% 1514
2021
Q1 		$160K Buy
+2,898
New +$176K ﹤0.01% 1459
2020
Q4 		– Sell
-5,326
Closed -$312K – 1547
2020
Q3 		$312K Buy
+5,326
New +$394K 0.01% 969
2018
Q3 		– Sell
-542
Closed -$227K – 1201
2018
Q2 		$227K Buy
+542
New +$183K 0.01% 893

Other funds holding OPTN

MPU
MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Paul Tudor Jones's OPTN Position: Q1 2022 in Review

Paul Tudor Jones sold out of OptiNose (OPTN) in Q1 2022, closing a stake of 3,124 shares — an estimated $76K sold.

Paul Tudor Jones first reported a position in OPTN in Q2 2018 and held it in 6 quarters. The position peaked at $312K in Q3 2020. 44 funds tracked by Wall St. Rank hold OPTN as of Q1 2022.

  • Paul Tudor Jones reported no remaining OptiNose position as of Q1 2022 after selling out during the quarter.
  • Paul Tudor Jones sold 3,124 OptiNose shares in Q1 2022, an estimated $76K.
  • Paul Tudor Jones first reported a position in OptiNose in Q2 2018 and held it in 6 quarters.
  • Paul Tudor Jones's OptiNose position peaked at $312K in Q3 2020.
  • 44 funds tracked by Wall St. Rank held OptiNose as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.